Amlodipine Besylate Tablet
Product Images NDC 69097-836

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 69097-836). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (0b202d42 F227 434c Ba39 2142c8a422d9 01)

Chemical structure of Amlodipine Besylate, showing the molecular arrangement of atoms including a chlorophenyl group, ester and amine functional groups, and the besylate moiety.*

FDA Label Image

Image (0b202d42 F227 434c Ba39 2142c8a422d9 02)

A line graph showing event rates over 24 months comparing Amlodipine versus placebo. The x-axis represents time in months, and the y-axis represents the event rate, with two curves: one for Amlodipine and one for placebo. The graph includes a P-value (0.003), hazard ratio (0.691), and 95% confidence interval (0.54 to 0.88). At-risk numbers are shown along the bottom for each time point.*

FDA Label Image

Image (0b202d42 F227 434c Ba39 2142c8a422d9 03)

A forest plot showing hazard ratios with 95% confidence intervals comparing the effect of Amlodipine versus placebo across various subgroups including overall patients, age groups, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata. The horizontal axis represents the hazard ratio scale from 0.0 to 2.0, indicating favor towards Amlodipine on the left and placebo on the right. A footnote states the mean sitting baseline systolic blood pressure is 129 mmHg.*

FDA Label Image

Image (0b202d42 F227 434c Ba39 2142c8a422d9 04)

Label for Amlodipine Besylate Tablets USP 2.5 mg by Cipla USA Inc., containing 90 tablets. The label includes storage instructions, dosage equivalence, manufacturer details including InvaGen Pharmaceuticals, Inc., a subsidiary of Cipla Ltd., and a barcode with additional product coding information.*

FDA Label Image

Image (0b202d42 F227 434c Ba39 2142c8a422d9 05)

Label for Amlodipine Besylate Tablets USP 5 mg by Cipla USA Inc. The label indicates 90 tablets per container, with storage instructions at 20°-25°C and protection from light. Manufactured by InvaGen Pharmaceuticals, a Cipla subsidiary, the label includes barcodes, a QR code, and directions to see accompanying prescribing information.*

FDA Label Image

Image (0b202d42 F227 434c Ba39 2142c8a422d9 06)

Amlodipine Besylate 10 mg Tablets, USP label displaying 90 tablets in the package. The label shows storage instructions, manufacturer info for InvaGen Pharmaceuticals, Inc., and Cipla USA Inc. as the labeler. It includes barcode and QR code with lot and expiration placeholders. Cipla is prominently noted as the labeler.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.